Anxo Pharmaceutical Co., Ltd.
Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, o… Read more
Market Cap & Net Worth: Anxo Pharmaceutical Co., Ltd. (6677)
Anxo Pharmaceutical Co., Ltd. (TWO:6677) has a market capitalization of $33.01 Million (NT$1.09 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #26347 globally and #1671 in its home market, demonstrating a -3.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anxo Pharmaceutical Co., Ltd.'s stock price NT$19.55 by its total outstanding shares 55871000 (55.87 Million).
Anxo Pharmaceutical Co., Ltd. Market Cap History: 2026 to 2026
Anxo Pharmaceutical Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $33.01 Million to $33.01 Million (0.00% CAGR).
Anxo Pharmaceutical Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anxo Pharmaceutical Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6677 by Market Capitalization
Companies near Anxo Pharmaceutical Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Anxo Pharmaceutical Co., Ltd. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Anxo Pharmaceutical Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Anxo Pharmaceutical Co., Ltd.'s market cap moved from $33.01 Million to $ 33.01 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$33.01 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Anxo Pharmaceutical Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.01 Million USD |
| MoneyControl | $33.01 Million USD |
| MarketWatch | $33.01 Million USD |
| marketcap.company | $33.01 Million USD |
| Reuters | $33.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.